Trading by management and close relations of management February 7, 2023 by GlobeNewsWire Leave a Comment Please read the … [Read more...] about Trading by management and close relations of management
Derm-Biome Pharmaceuticals to Present at the 2023 OBIO Investment Summit on February 10, 2023 February 7, 2023 by GlobeNewsWire Leave a Comment VANCOUVER, British … [Read more...] about Derm-Biome Pharmaceuticals to Present at the 2023 OBIO Investment Summit on February 10, 2023
Elektrofi Announces Collaboration with Thermo Fisher Scientific to Strengthen Manufacturing Capabilities for Future Clinical Trials February 7, 2023 by GlobeNewsWire Leave a Comment BOSTON, Feb. 07, … [Read more...] about Elektrofi Announces Collaboration with Thermo Fisher Scientific to Strengthen Manufacturing Capabilities for Future Clinical Trials
Cytek(R) Biosciences Partners with Bio-Rad to Expand Reagent Portfolios February 7, 2023 by GlobeNewsWire Leave a Comment FREMONT, Calif., … [Read more...] about Cytek(R) Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
Nearly Three Out of Four Colorado Smokers Want to Quit and Now Have a New Option That “Helps You Smoke Less” February 7, 2023 by GlobeNewsWire Leave a Comment VLN(R), a … [Read more...] about Nearly Three Out of Four Colorado Smokers Want to Quit and Now Have a New Option That “Helps You Smoke Less”
Pliant Therapeutics to Participate in Upcoming Investor Events February 7, 2023 by GlobeNewsWire Leave a Comment SOUTH SAN … [Read more...] about Pliant Therapeutics to Participate in Upcoming Investor Events
Selecta Biosciences to Participate at the SVB Securities Global Biopharma Conference February 7, 2023 by GlobeNewsWire Leave a Comment WATERTOWN, Mass., … [Read more...] about Selecta Biosciences to Participate at the SVB Securities Global Biopharma Conference
RAPT Therapeutics to Participate in the SVB Securities Global Biopharma Conference February 7, 2023 by GlobeNewsWire Leave a Comment SOUTH SAN … [Read more...] about RAPT Therapeutics to Participate in the SVB Securities Global Biopharma Conference
Immix Biopharma Announces Dosing of First 2 Patients in its IMX-110 + BeiGene/Novartis anti-PD-1 Tislelizumab Phase 1b/2a Combination Clinical Trial in Patients with Advanced Cancer February 7, 2023 by GlobeNewsWire Leave a Comment IMX-110 + … [Read more...] about Immix Biopharma Announces Dosing of First 2 Patients in its IMX-110 + BeiGene/Novartis anti-PD-1 Tislelizumab Phase 1b/2a Combination Clinical Trial in Patients with Advanced Cancer
CENTOGENE Regains Compliance With Nasdaq Listing Requirements February 7, 2023 by GlobeNewsWire Leave a Comment CAMBRIDGE, Mass. … [Read more...] about CENTOGENE Regains Compliance With Nasdaq Listing Requirements
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Portuguese
Russian
Spanish
You must be logged in to post a comment.